Lineage Cell Therapeutics, Inc. (LCTX)

USD 0.5

(0.93%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 101.01 Million 123.66 Million 174.54 Million 107.94 Million 125.47 Million 101.66 Million
Total Current Assets 38.44 Million 60 Million 111.54 Million 43.99 Million 57.51 Million 36.35 Million
Cash And Short Term Investments 35.49 Million 57.87 Million 58.35 Million 41.56 Million 30.71 Million 30.74 Million
Cash and Cash Equivalents 35.44 Million 11.35 Million 55.74 Million 32.58 Million 9.49 Million 23.58 Million
Short Term Investments 50 Thousand 46.52 Million 2.61 Million 8.97 Million 21.21 Million 7.15 Million
Net Receivables 745 Thousand 297 Thousand 50.84 Million 4000.00 23.94 Million 3.71 Million
Inventory - 1.00 - - 1.00 1.00
Other Current Assets 2.2 Million 1.82 Million 2.35 Million 2.43 Million 2.86 Million 1.89 Million
Total Non-Current Assets 62.57 Million 63.66 Million 62.99 Million 63.95 Million 67.95 Million 65.3 Million
Net PPE 4.76 Million 5.67 Million 4.87 Million 5.63 Million 8.17 Million 5.83 Million
Good Will And Intangible Assets 57.23 Million 57.36 Million 57.49 Million 57.7 Million 58.92 Million 3.12 Million
Good Will 10.67 Million 10.67 Million 10.67 Million 10.67 Million 10.67 Million -
Intangible Assets 46.56 Million 46.69 Million 46.82 Million 47.03 Million 48.24 Million 3.12 Million
Long-Term Investments 550 Thousand 581 Thousand 535 Thousand 520 Thousand 100 Thousand 33.73 Million
Tax Assets - -581 Thousand -535 Thousand -520 Thousand -100 Thousand 22.1 Million
Other Non Current Assets 27 Thousand 627 Thousand 630 Thousand 616 Thousand 864 Thousand 505 Thousand
Other Assets - - - - - -
Total Liabilities 38.99 Million 51.72 Million 83.64 Million 12.82 Million 14.23 Million 9.41 Million
Total Current Liabilities 17.96 Million 18.98 Million 47.11 Million 7.76 Million 6.49 Million 6.81 Million
Account Payables 2.04 Million 2.39 Million 3.54 Million 2.61 Million 5.22 Million 6.46 Million
Tax Payables - - - - - -
Short Term Debt 882 Thousand 952 Thousand 831 Thousand 762 Thousand 1.22 Million 307 Thousand
Deferred Revenue 10.8 Million 9.42 Million 18.11 Million 193 Thousand 45 Thousand 42 Thousand
Other Current Liabilities 4.22 Million 6.21 Million 24.62 Million 4.2 Million - -
Total Non Current Liabilities 21.03 Million 32.74 Million 36.53 Million 5.05 Million 7.73 Million 2.6 Million
Long-Term Debt 2.07 Million 2.94 Million 1.97 Million 2.54 Million 3.94 Million 1.95 Million
Deferred Revenue Non Current 18.69 Million 27.72 Million 32.45 Million - 200 Thousand -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities - 2000.00 30 Thousand 437 Thousand 277 Thousand 644 Thousand
Other Liabilities - - - - - -
Total Equity 62.02 Million 71.93 Million 90.89 Million 95.12 Million 111.24 Million 92.24 Million
Stock Holders Equity 63.41 Million 73.33 Million 92.22 Million 96.19 Million 112.95 Million 93.84 Million
Common Stock 451.34 Million 440.28 Million 434.52 Million 393.94 Million 387.06 Million 354.27 Million
Retained Earnings -384.85 Million -363.37 Million -337.09 Million -294.07 Million -273.42 Million -261.85 Million
Accumulated other comprehensive income -3.06 Million -3.57 Million -5.21 Million -3.66 Million -681 Thousand 1.42 Million
Common Stock Equity 63.41 Million 73.33 Million 92.22 Million 96.19 Million 112.95 Million 93.84 Million
Capital Lease Obligation 2.06 Million 3.89 Million 2.8 Million 3.3 Million 5.16 Million 2.19 Million
Total Investments 600 Thousand 46.52 Million 2.61 Million 8.97 Million 21.21 Million 40.88 Million
Total Debt 2.95 Million 3.89 Million 2.8 Million 3.3 Million 5.16 Million 2.26 Million
Net Debt -32.49 Million -7.45 Million -52.94 Million -29.28 Million -4.32 Million -21.32 Million

Balance Sheet Charts